Epigenetics and the heart

Written byIvan Oransky

| 2 min read

Epigenetics and chromatin remodeling, it turns out, may play a role in heart disease. In one of two keynote addresses that opened the Keystone Symposia?s meeting on Molecular Mechanisms of Cardiac Disease and Regeneration here in Santa Fe, New Mexico, linkurl:Eric Olson;http://hamon.swmed.edu/faculty/olson2001.html showed why he?s received a number of awards from the American Heart Association, and why one of his earlier papers, linking calcineurin to cardiac hypertrophy, was a linkurl:Hot Paper;http://www.the-scientist.com/article/display/11943/ in 2000. The highlight of Olson?s talk was data on a linkurl:HDAC7;http://circres.ahajournals.org/cgi/content/abstract/98/1/15 ?- chromatin remodeling enzyme histone deacetylase 7 -- mouse knockout that died a massive cardiac death during embryonic development. The mice are fine until day 11, but by day 11.5, they?ve bled out, having suffered vascular dilatation, heart failure, and pericardial effusion. In the knockouts, smooth muscle cells are recruited to the vasculature, but they never become organized, the result of defects in endothelial cell adhesion that lead to a lack of tight junctions. Olson?s group has replicated the findings in human umbilical vein endothelial cells treated with RNAi that targets HDAC7. In vitro, such cells normally form vascular structures, but after RNAi treatment, they don?t. Taking the work to the gene function level, the team found that matrix metalloproteinase 10 (MMP10) ? a member of a family of proteins involved in degradation of the extracellular matrix ? was upregulated 6.5-fold, while tissue inhibitors of MMPs, or TIMPs, were downregulated, suggesting one potential mechanism of action ? repression of MMP10 ? for HDAC7. Many things remain unclear about the role of HDAC7, but its previous association with atherosclerosis, in which it is upregulated, and Olson?s dramatic knockout findings, generated a great deal of interest and questioning. The meeting will continue in Olson?s vein for a few days of talks and posters on molecular mechanisms of cardiac disease, and will then shift its focus to regeneration, which was the subject of Randall Moon?s talk that preceded Olson?s. It appears from looking at the agenda that in many cases, regeneration here means using stem cells to repair cardiomyocyte damage. Stay tuned for notes about Moon and other presentations.

Epigenetics and the heart

The Scientist ARCHIVES

Become a Member of

Meet the Author

Ivan Oransky

Related Research Resources

A Stubborn Gene, a Failed Experiment, and a New Path

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Advancing Drug Discovery with Complex Human In Vitro Models

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Maximizing Cancer Research Model Systems

Products

Product News

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies